Matches in Wikidata for { <http://www.wikidata.org/entity/Q64643373> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q64643373 description "clinical trial" @default.
- Q64643373 description "ensayu clínicu" @default.
- Q64643373 description "klinisch onderzoek" @default.
- Q64643373 description "клінічне випробування" @default.
- Q64643373 description "կլինիկական փորձարկում" @default.
- Q64643373 name "MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone" @default.
- Q64643373 type Item @default.
- Q64643373 label "MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone" @default.
- Q64643373 prefLabel "MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone" @default.
- Q64643373 P1050 Q64643373-2AD2DC66-832C-4A54-AB3E-65CB266D7D20 @default.
- Q64643373 P1050 Q64643373-CD1E49CB-CA15-42D5-B1A6-C47E2198B3FA @default.
- Q64643373 P1132 Q64643373-7C7E30F2-613E-4CC3-A700-8AEC88BCA082 @default.
- Q64643373 P131 Q64643373-17FA2F8D-8B2D-4CA9-98B5-C7162111C628 @default.
- Q64643373 P1476 Q64643373-6234D108-2090-4C4B-9DEB-BD7042B081AA @default.
- Q64643373 P17 Q64643373-296E1D8B-6305-4FAC-848E-58FDA3D273FB @default.
- Q64643373 P17 Q64643373-46A1E05C-B34C-4C9A-A86E-0C6342C662BE @default.
- Q64643373 P17 Q64643373-A60780B9-27BB-4265-9F75-07884881B67F @default.
- Q64643373 P17 Q64643373-AC6C2411-D101-4C83-95F0-4599890378B5 @default.
- Q64643373 P17 Q64643373-BE1B6E9F-FF91-4026-BA89-5773ACD8DD76 @default.
- Q64643373 P17 Q64643373-EE50E9EE-456E-4988-84DC-F298A30C76FC @default.
- Q64643373 P2899 Q64643373-BE6E7D3C-50F0-4AD0-9DA1-BE1A8A310C84 @default.
- Q64643373 P3098 Q64643373-7DFAF5A5-7C8E-4DCE-9033-B5B0D58B280D @default.
- Q64643373 P31 Q64643373-653397E9-2C63-4E5B-B904-01B1EAD7258E @default.
- Q64643373 P4135 Q64643373-EC256657-44D4-49DF-9365-68E1D5E7E02E @default.
- Q64643373 P580 Q64643373-3D7635DB-75F4-477D-8204-64E7B4923F17 @default.
- Q64643373 P582 Q64643373-06821F6F-B002-425E-B4D8-2C1910D39500 @default.
- Q64643373 P6099 Q64643373-61CF2DB7-3250-41AA-AFB1-2343B30E2FE7 @default.
- Q64643373 P6153 Q64643373-1215B325-04B3-4D9D-B703-8A2528729375 @default.
- Q64643373 P8363 Q64643373-8FC51955-06F7-469C-AC89-27B404D23AFA @default.
- Q64643373 P859 Q64643373-964E1CC5-105B-45E0-A94F-B0D6B5BE08BB @default.
- Q64643373 P1050 Q140067 @default.
- Q64643373 P1050 Q8277 @default.
- Q64643373 P1132 "+1064" @default.
- Q64643373 P131 Q1183 @default.
- Q64643373 P1476 "A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis" @default.
- Q64643373 P17 Q155 @default.
- Q64643373 P17 Q16 @default.
- Q64643373 P17 Q298 @default.
- Q64643373 P17 Q30 @default.
- Q64643373 P17 Q414 @default.
- Q64643373 P17 Q96 @default.
- Q64643373 P2899 "+18" @default.
- Q64643373 P3098 "NCT01633112" @default.
- Q64643373 P31 Q30612 @default.
- Q64643373 P4135 "+65" @default.
- Q64643373 P580 "2012-08-09T00:00:00Z" @default.
- Q64643373 P582 "2018-04-30T00:00:00Z" @default.
- Q64643373 P6099 Q42825046 @default.
- Q64643373 P6153 Q507154 @default.
- Q64643373 P8363 Q78089383 @default.
- Q64643373 P859 Q507154 @default.